Potential of 4'-C-substituted nucleosides for the treatment of HIV-1.
Hayakawa
Hiroyuki
H
Biochemicals Division, Yamasa Corporation, Chiba, Japan. hayakawa@yamasa.com
Kohgo
Satoru
S
Kitano
Kenji
K
Ashida
Noriyuki
N
Kodama
Eiichi
E
Mitsuya
Hiroaki
H
Ohrui
Hiroshi
H
D019380:Anti-HIV Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D009705:Nucleosides / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D019380:Anti-HIV Agents; D009705:Nucleosides